AVERNA, Maurizio
 Distribuzione geografica
Continente #
NA - Nord America 31.257
EU - Europa 14.787
AS - Asia 12.465
SA - Sud America 2.257
Continente sconosciuto - Info sul continente non disponibili 1.756
AF - Africa 359
OC - Oceania 31
Totale 62.912
Nazione #
US - Stati Uniti d'America 30.598
SG - Singapore 4.432
RU - Federazione Russa 3.500
IT - Italia 3.387
CN - Cina 3.189
BR - Brasile 1.768
FI - Finlandia 1.661
VN - Vietnam 1.225
UA - Ucraina 1.216
HK - Hong Kong 1.210
DE - Germania 1.157
PL - Polonia 819
IE - Irlanda 686
GB - Regno Unito 685
FR - Francia 682
JP - Giappone 470
BD - Bangladesh 454
CA - Canada 336
KR - Corea 289
IN - India 271
SE - Svezia 244
TR - Turchia 181
AR - Argentina 155
NL - Olanda 155
MX - Messico 151
AT - Austria 113
IQ - Iraq 112
BE - Belgio 99
CI - Costa d'Avorio 80
ZA - Sudafrica 76
RO - Romania 73
EC - Ecuador 68
PK - Pakistan 67
VE - Venezuela 66
CO - Colombia 64
ES - Italia 63
UZ - Uzbekistan 58
CH - Svizzera 56
ID - Indonesia 55
MY - Malesia 51
CL - Cile 50
JM - Giamaica 47
MA - Marocco 47
SA - Arabia Saudita 41
IR - Iran 40
GR - Grecia 36
JO - Giordania 36
AE - Emirati Arabi Uniti 34
KE - Kenya 33
NP - Nepal 33
PH - Filippine 32
CR - Costa Rica 31
AZ - Azerbaigian 29
PY - Paraguay 29
EG - Egitto 25
PE - Perù 25
TW - Taiwan 25
AU - Australia 23
DZ - Algeria 20
LT - Lituania 19
CZ - Repubblica Ceca 18
IL - Israele 18
PT - Portogallo 18
HN - Honduras 17
UY - Uruguay 17
BG - Bulgaria 15
BO - Bolivia 15
KZ - Kazakistan 14
SN - Senegal 14
TH - Thailandia 14
TN - Tunisia 14
TT - Trinidad e Tobago 13
GE - Georgia 12
AL - Albania 11
DO - Repubblica Dominicana 11
PA - Panama 11
NG - Nigeria 10
OM - Oman 10
BH - Bahrain 9
NI - Nicaragua 9
RS - Serbia 9
HU - Ungheria 8
NO - Norvegia 8
PS - Palestinian Territory 8
AO - Angola 7
DK - Danimarca 7
GT - Guatemala 7
HR - Croazia 7
LB - Libano 7
LK - Sri Lanka 7
MM - Myanmar 7
NZ - Nuova Zelanda 7
EU - Europa 6
PR - Porto Rico 6
QA - Qatar 6
SI - Slovenia 6
BY - Bielorussia 5
ET - Etiopia 5
KG - Kirghizistan 5
MD - Moldavia 5
Totale 61.080
Città #
Fairfield 3.655
Ashburn 3.633
Singapore 2.959
Woodbridge 1.901
San Jose 1.900
Houston 1.637
Wilmington 1.561
Seattle 1.551
Chandler 1.523
Cambridge 1.171
Hong Kong 1.161
Ann Arbor 849
Council Bluffs 731
Zgierz 721
Dublin 681
Jacksonville 648
Moscow 583
Medford 545
Beijing 530
Palermo 479
Tokyo 445
Santa Clara 416
Ho Chi Minh City 396
Dallas 379
Nanjing 375
New York 365
Los Angeles 362
Altamura 358
Princeton 345
Frankfurt am Main 339
Lauterbourg 324
Helsinki 306
Hanoi 279
Boardman 267
Des Moines 265
San Diego 259
Lawrence 249
Dearborn 209
Milan 199
Chicago 191
Tulsa 178
Hefei 165
Buffalo 158
São Paulo 146
Shenyang 136
London 125
Rome 123
The Dalles 109
Nanchang 108
Toronto 102
Jinan 96
Hebei 91
Orem 91
Tianjin 90
Changsha 88
Brussels 87
Ludwigshafen am Rhein 87
Seongnam 86
Phoenix 83
Abidjan 80
Izmir 76
Munich 74
Jiaxing 67
Atlanta 63
Guangzhou 62
Da Nang 60
Haiphong 60
Rio de Janeiro 59
Mumbai 57
Nuremberg 57
Saint Petersburg 57
Amsterdam 55
Columbus 55
Chennai 51
Düsseldorf 48
Johannesburg 48
Montreal 48
Ningbo 48
Salt Lake City 47
Venice 47
Warsaw 47
Belo Horizonte 45
Zhengzhou 45
Brooklyn 44
Shanghai 44
Tashkent 44
Verona 43
Naples 40
Paris 40
Baghdad 39
San Mateo 39
Vienna 39
San Francisco 38
San Paolo di Civitate 38
Hangzhou 37
Stockholm 37
Bremen 36
Boston 35
Denver 35
Brasília 34
Totale 38.914
Nome #
Multiple food hypersensitivity as a cause of refractory chronic constipation in adults 518
Le Dislipidemie Genetiche. Il Progetto LIPIGEN 438
The polygenic nature of hypertriglyceridaemia: implications for definition, diagnosis, and management. 424
Efficacy and safety of alirocumab in reducing lipids and cardiovascular events 421
A novel mutation of the extracellular matrix protein 1 gene (ECM1) in a patient with lipoid proteinosis (Urbach-Wiethe disease) from Sicily 312
Efficacy and safety of adding alirocumab to rosuvastatin versus adding ezetimibe or doubling the rosuvastatin dose in high cardiovascular-risk patients: The ODYSSEY OPTIONS II randomized trial 307
Association between HFE mutations and acute myocardial infarction: a study in patients from Northern and Southern Italy 299
Accumulation of apoE-enriched triglyceride-rich lipoproteins in patients with coronary artery disease 296
Familial hypercholesterolaemia in children and adolescents from 48 countries: a cross-sectional study 294
CEREBROTENDINOUS XANTHOMATOSIS: A SICILIAN FAMILY HARBOURING THE R362C MUTATION IN THE STEROL 27-HYDROXYLASE GENE 293
TERAPIA CON STATINE IN PAZIENTI SICILIANI AFFETTI DA IPERLIPIDEMIA FAMILIARE COMBINATA 292
LINEE GUIDA CLINICHE PER LA PREVENZIONE DELLA CARDIOPATIA ISCHEMICA NELLA IPERCOLESTEROLEMIA FAMILIARE Una patologia sotto-diagnosticata e sotto-trattata 292
A NOVEL APOB MUTATION IDENTIFIED BY EXOME SEQUENCING COSEGREGATES WITH STEATOSIS, LIVER CANCER AND HYPOCHOLESTEROLEMIA 286
Platelet Count Does Not Predict Bleeding in Cirrhotic Patients: Results from the PRO-LIVER Study 276
IL GENE PCSK9: UN NUOVO GENE IMPLICATO NEL CONTROLLO DELLA COLESTEROLEMIA 274
ApoE polymorphism in a small Mediterranean island: Relationships with plasma lipids, lipoproteins and LDL particle size 274
Resting energy expenditure and substrate oxidation in malnourished patients with type 1 glycogenosis 271
A NOVEL COMPOUND HETEROZYGOUS MUTATION OF THE LIPOPROTEIN LIPASE GENE IN A NEWBORN WITH CHYLOMICRONEMIA 270
Major adverse cardiovascular events in non-valvular atrial fibrillation with chronic obstructive pulmonary disease: the ARAPACIS study 268
Behavior of the total antioxidant status in a group of subjects with metabolic syndrome. 267
A NOVEL NONSENSE MUTATION IN THE CETP GENE IN ITALIAN HYPERALPHALIPOPROTEINEMIC SUBJECTS 266
Interleukin 6 plasma levels predict with high sensitivity and specificity coronary stenosis detected by coronary angiography 265
The production of 85 kDa N-terminal fragment of apolipoprotein B in mutant HepG2 cells generated by targeted modification of apoB gene occurs by ALLN-inhibitable protease cleavage during translocation. 264
C-reactive protein but not soluble CD40 ligand and homocysteine is associated to common atherosclerotic risk factors in a cohort of coronary artery disease patients. 262
Familial hypercholesterolaemia is underdiagnosed and undertreated in the general population: guidance for clinicians to prevent coronary heart disease: Consensus Statement of the European Atherosclerosis Society 262
CLINICAL AND MOLECULAR CHARACTERIZATION OF HYPERCHOLESTEROLEMIC SICILIAN FAMILIES AND DESCRIPTION OF 3 NOVEL MUTATIONS IN THE LDLR GENE 260
Genetic epidemiology of autosomal recessive hypercholesterolemia in Sicily: Identification by next-generation sequencing of a new kindred 260
BETA-2-GLYCOPROTEIN I IS GROWTH REGULATED AND PLAYS A ROLE AS SURVIVAL FACTOR FOR HEPATOCYTES 258
FragClust and TestClust, two informatics tools for chemical structure hierarchical clustering analysis applied to lipidomics. The example of Alzheimer's disease 257
REDUCTION OF CHOLESTEROL WITH NUTRACEUTICAL: RESULTS OF A DOUBLE BLIND STUDY 256
Baseline metabolic disturbances and the twenty-five years risk of incident cancer in a Mediterranean population 256
Chronic constipation and food intolerance: a model of proctitis causing constipation 255
The metabolic syndrome predicts cardiovascular events in subjects with normal fasting glucose: Results of a 15 years follow-up in a Mediterranean population. 252
A novel loss of function mutation of PCSK9 gene in white subjects with low-plasma low-density lipoprotein cholesterol. 252
Six novel mutations of the LDL receptor gene in FH kindred of Sicilian and Paraguayan descent 250
PCSK9-D374Y mediated LDL-R degradation can be functionally inhibited by EGF-A and truncated EGF-A peptides: An in vitro study 250
Association between apolipoprotein E epsilon4 allele and apathy in probable Alzheimer's disease. 248
Familial hypercholesterolemia: The Italian Atherosclerosis Society Network (LIPIGEN) 248
A Novel Mutation of the DHCR7 Gene in a Sicilian Compound Heterozygote with Smith-Lemli-Opitz Syndrome 247
PREVALENCE OF APOB VARIANTS IN A SAMPLE OF SUBJECTS WITH HYPOCHOLESTEROLEMIA 245
Diagnostic accuracy of fecal calprotectin assay in distinguishing organic causes of chronic diarrhea from irritable bowel syndrome: a prospective study in adults and children 244
Association of estrogen receptor alpha gene with Alzheimer's disease: a case-control study 242
Analysis of sterols by high-performance liquid chromatography/mass spectrometry combined with chemometrics 242
GASTROINTESTINAL SYMPTOMS IN INFANCY: A POPULATION-BASED PROSPECTIVE STUDY 241
Heparin induces an accumulation of atherogenic lipoproteins during hemodialysis in normolipidemic end-stage renal disease patients. 240
A novel putative interactor for the low density lipoprotein receptor cytoplasmic domain 238
A novel component of the metabolic syndrome : The oxidative stress 237
Familial hypobetalipoproteinemia due to apolipoprotein B R463W mutation causes intestinal fat accumulation and low postprandial lipemia. 235
A polymorphism in the cyclooxygenase 2 gene as an inherited protective factor against myocardial infarction and stroke 234
INTERLEUKIN 6 PLASMA LEVELS PREDICT WITH HIGH SENSITIVITY AND SPECIFICITY CORONARY STENOSIS DETECTED BY CORONARY ANGIOGRAPHY 233
LIPIDOMICS OF FATTY LIVER IN NAFLD AND HCV INFECTION: LIVER SPHYNGOLIPIDS AND FATTY ACIDS 231
RUOLO DEL POLIMORFISMO ILE148MET DEL GENE PNPLA3 NELLA STEATOSI ASSOCIATA ALLA IPOBETALIPOPROTEINEMIA FAMILIARE 231
Anti-actin antibodies in celiac disease: correlation with intestinal mucosa damage and comparison of ELISA with the immunofluorescence assay. 230
Clinical, pathologic, and genetic features of massive soft tissue neurofibromas in a Sicilian patient 230
Genotypic and phenotypic characterization of patients with autosomal dominant hypercholesterolemia in sicily 230
Modification of the lipidic and coagulative pattern in postmenopause women: effect of hormone replacement therapy. 229
Apolipoprotein AI and HDL are reduced in stable cirrhotic patients with adrenal insufficiency: A possible role in glucocorticoid deficiency 224
Identification of a novel LMF1 nonsense mutation responsible for severe hypertriglyceridemia by targeted next-generation sequencing 224
Familial hypercholesterolæmia in children and adolescents: Gaining decades of life by optimizing detection and treatment 224
Prediction of incident type 2 diabetes mellitus based on a twenty-year follow-up of the Ventimiglia heart study 223
ANMCO/ISS/AMD/ANCE/ARCA/FADOI/GICR-IACPR/SICI-GISE/SIBioC/SIC/SICOA/SID/SIF/SIMEU/SIMG/SIMI/SISA Joint Consensus Document on cholesterol and cardiovascular risk: Diagnostic-therapeutic pathway in Italy 222
Albumin versus solvent/detergent-treated pooled plasma as replacement fluid for long-term plasma exchange therapy in a patient with primary hypertriglyceridemia and recurrent hyperlipidemic pancreatitis 222
Hypertension and diabetes mellitus are associated with cardiovascular events in the elderly without cardiovascular disease. Results of a 15-year follow-up in a Mediterranean population 221
SEVERE MALABSORPTION AND DECREASED TRIGLYCERIDE RICH LIPOPROTEINS PRODUCTION IN A PROBAND CARRYING A MUTATION ENCODING FOR A TRUNCATED APOLIPOPROTEIN B100 VARIANT (APO B 34.8). 219
Decreased plasma soluble RAGE in patients with hypercholesterolemia: Effects of statins 219
A Novel APOB Mutation Identified by Exome Sequencing Cosegregates With Steatosis, Liver Cancer, and Hypocholesterolemia. 219
LE IPERCOLESTEROLEMIE PRIMITIVE 217
Plasma non-cholesterol sterols: a useful diagnostic tool in pediatric hypercholesterolemia. 217
Bovine seminal ribonuclease is cytotoxic for both malignant and normal telomerase-positive cells 216
The ANP Genetic Variant RS5068 is Associated With a Favorable Cardiometabolic Phenotype in a Mediterranean Population 215
Efficacy and Safety of Ezetimibe Added to Atorvastatin Versus Atorvastatin Uptitration or Switching to Rosuvastatin in Patients With Primary Hypercholesterolemia 215
Metabolomic analysis of plasma from Alzheimer disease patients 214
LA LIPIDOMICA DELLA NON ALCOHOLIC FATTY LIVER DISEASE: ANALISI DELLA CINETICA DELL’ACIDO PALMITICO MEDIANTE L’USO DI UN ISOTOPO STABILE IN UN MODELLO IN VITRO 214
Identification and diagnosis of patients with familial chylomicronaemia syndrome (FCS): Expert panel recommendations and proposal of an “FCS score” 214
Lipid-altering efficacy of ezetimibe/simvastatin 10/20 mg compared with rosuvastatin 10 mg in high-risk hypercholesterolaemic patients inadequately controlled with prior statin monotherapy - The IN-CROSS study. 213
HYPOBETALIPOPROTEINEMIA AND FATTY LIVER: WHO IS THE CULPRIT 213
Lipoprotein-associated phospholipase A2 activity is increased in patients with definite familial hypercholesterolemia compared with other forms of hypercholesterolemia 213
Obesity and the metabolic syndrome in a student cohort from Southern Italy 211
FAMILIAL LIGAND-DEFECTIVE APOLIPOPROTEIN B: IDENTIFICATION OF A FAMILY HARBOURING THE ARG3531CYS (FDB3531) OF THE APOB GENE 210
No association between the cystatin C gene polymorphism and Alzheimer's disease: a case-control study in an Italian population. 210
Myristic acid is associated to low plasma HDL cholesterol levels in a Mediterranean population and increases HDL catabolism by enhancing HDL particles trapping to cell surface proteoglycans in a liver hepatoma cell model 210
Gene expression in mouse spermatogenesis during ontogenesis. 209
Cardiovascular efficacy and safety of bococizumab in high-risk patients 209
A Targeted ApoB38.9 Mutation in Mice Is Associated with Reduced Hepatic Cholesterol Synthesis and Enhanced Lipid Peroxidation. 208
Transient chylomicronemia preceding the onset of insulin-dependent diabetes in a young girl with no humoral markers of islet autoimmunity. 208
MISSENSE MUTATION ALA34VAL IN EXON 2 OF THE LIPOPROTEIN LIPASE GENE IN A YOUNG MAN WITH CHYLOMICRONEMIA. 207
Low-density lipoproteins generated during an oral fat load in mild hypertriglyceridemic and healthy subjects are smaller, denser, and have an increased low-density lipoprotein receptor binding affinity. 207
Cystatin C levels are decreased in acute myocardial infarction: Effect of cystatin C G73A gene polymorphism on plasma levels 207
CLINICAL CHARACTERISTICS AND PLASMA LIPIDS IN SUBJECTS WITH FAMILIAL COMBINED HYPOLIPIDEMIA: A POOLED ANALYSIS 207
LDL peak particle size and the extension of coronary atherosclerosis in 72 patients that underwent an angiographic exam 207
Molecular diagnosis of hypobetalipoproteinemia: An ENID review 206
Novel mutations of CETP gene in Italian subjects with hyeralphalipoproteinemia 206
Enhanced Lipid Peroxidation and Platelet Activation as Potential Contributors to Increased Cardiovascular Risk in the Low-HDL Phenotype 205
Role of Nutraceuticals in Hypolipidemic Therapy 204
A novel mutation in the Lipase Maturaction Factor 1 (LMF-1)gene responsible for severe hypertriglyceridemia 203
Autosomal recessive hypercholesterolemia in a Sicilian kindred harboring the 432insA mutation of the ARH gene. 203
Relationship of a Body Shape Index and Body Roundness Index with carotid atherosclerosis in arterial hypertension 202
Changes in plasma lipids and low-density lipoprotein peak particle size during and after acute myocardial infarction 201
Determinants of enhanced thromboxane biosynthesis in renal transplantation 201
Clinical and biochemical characteristics of individuals with low cholesterol syndromes: A comparison between familial hypobetalipoproteinemia and familial combined hypolipidemia 200
Totale 24.571
Categoria #
all - tutte 215.955
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 215.955


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/20223.750 0 837 146 125 102 152 169 229 543 481 231 735
2022/20234.678 503 934 113 485 550 713 203 323 499 58 190 107
2023/20242.310 106 339 164 253 164 513 241 118 28 72 60 252
2024/20256.171 151 323 405 468 230 228 427 495 525 632 844 1.443
2025/202621.667 1.330 771 1.176 1.508 1.823 3.052 3.026 2.293 1.782 2.983 940 983
2026/20271.773 1.108 665 0 0 0 0 0 0 0 0 0 0
Totale 62.912